Strides Pharma subsidiary gets FDA approval for Icosapent Ethyl Capsules

By on    Pharma Industry News  

Strides Pharma subsidiary gets FDA approval for Icosapent Ethyl Capsules

In a significant pharmaceutical breakthrough, Strides Pharma Science Limited announces that its wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has secured the coveted approval from the United States Food & Drug Administration (FDA) for Icosapent Ethyl Capsules in both 0.5 gram and 1 gram variants. These capsules are not just any pharmaceutical innovation; […]

Amarin bags Vascepa FDA approval for reducing cardiovascular risk

By on    Pharma Industry News  

Amarin bags Vascepa FDA approval for reducing cardiovascular risk

Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA) for a new indication and label expansion for Vascepa (icosapent ethyl) capsules. The FDA has now approved Vascepa as an adjunctive (secondary) therapy to cut down the risk of cardiovascular events in adults having elevated triglyceride levels, […]